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ABSTRACT The gene-trap lacZ reporter insertion, ROSA11, in the Cbx5 mouse gene illuminates the
regulatory complexity of this locus in ApcMin/+ mice. The insertion site of the b-Geo gene-trap element
lies in the 24-kb intron proximal to the coding region of Cbx5. Transcript analysis indicates that two
promoters for Cbx5 ﬂank this insertion site. Heterozygotes for the insertion express lacZ widely in fetal
tissues but show limited expression in adult tissues. In the intestine, strong expression is limited to pro-
liferative zones of crypts and tumors. Homozygotes for ROSA11, found at a lower than Mendelian fre-
quency, express reduced levels of the coding region transcript in normal tissues, using a downstream
promoter. Analysis via real-time polymerase chain reaction indicates that the upstream promoter is the
dominant promoter in normal epithelium and tumors. Bioinformatic analysis of the Cbx5 locus indicates that
WNT and its target transcription factor MYC can establish a feedback loop that may play a role in regulating
the self-renewal of the normal intestinal epithelium and its tumors.
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A core strategy of current efforts to understand development and
neoplasia is to document differential patterns of gene expression
and deduce the genetic control over those patterns. Documentation
of the pattern of gene expression takes several forms: transcriptome
analyses of whole tissues reveal changes in transcript levels measured
by hybridization to arrays or by the comparison of transcript copy
numbers identiﬁed by deep sequencing in differentiating or neoplastic
lineages. Alternatively, spatial and temporal patterns of gene expres-
sion can be visualized at cellular resolution by tagging each active gene
using random transposon insertions. Here, a marker tag enables both
the cloning of the active gene and visualization of its activity (Starr
et al. 2011).
The genetic control of developmental and neoplastic processes is
deduced by analysis of changes in spatial or temporal expression
patterns that are elicited by mutations in relevant genes. These
mutations may be studied singly or in combination. Loss-of-function
alleles tagged with reporters provide a particularly powerful entry into
the analysis of a system of genetic control. The heterozygote displays
the pattern of expression of the gene of interest (Austin et al. 2004),
and the homozygote reveals whether the gene’s activity is a necessary
element in a biological feedback loop with positive or negative parity
(Brenner et al. 1990; Thomas 1998).
Soriano et al. initiated the transposon-tagging approach to study
development in the mouse by transforming embryonic stem (ES) cells
with the promoter-trap vector ROSAb-geo1-29. This reporter gene
encodes a fusion protein, b-Geo, with both b-galactosidase (b-GAL)
and neomycin phosphotransferase activity (Friedrich and Soriano
1991). One of the strains developed in this program, ROSA11
(R11), has drawn our attention because it expresses a b-GAL differ-
entiation marker that is strongly expressed in the proliferative zone of
intestinal crypts and in intestinal adenomas of Min mice (Gould and
Dove 1996). By contrast, another of Soriano et al.’s promoter trap
mouse strains, ROSA26, is expressed pervasively in the adult mouse
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et al. 1997; Thliveris et al. 2005).
This report provides evidence that the R11 i n s e r t i o nl i e sw i t h i nt h e
heterochromatin protein 1a locus Cbx5 on mouse chromosome 15. A
detailed informatic analysis of the structure of this locus and a molec-
ular analysis of its expression in normal and neoplastic tissues has
uncovered a complex system of regulation of this locus. Our under-
standing of the biology of the normal self-renewing intestinal epithe-
lium and its neoplastic derivative is enhanced by these observations.
MATERIALS AND METHODS
Mouse strains, breeding, and maintenance
The congenic C57BL/6 (B6) R11 strain was derived from a single
heterozygous male generously provided by P. Soriano (Baylor University,
Houston TX) by backcrossing to B6 for 10 generations. The congenic B6
ApcMin/+ mice were obtained from our colony (Moser et al. 1990). The
doubly heterozygous R11/+ Min/+ animals were obtained by crossing
R11/+ females to Min/+ males. Homozygous R11/R11 Min/+ mice were
obtained by crossing R11/+ females to R11/+ Min/+ males. Mice were
maintained under a protocol approved by the Animal Care and Use
Committee of the University of Wisconsin School of Medicine and
Public Health and in a facility in the McArdle Laboratory approved
by the American Association of Laboratory Animal Care. Animals were
housed in standard caging with free access to mouse chow and acidiﬁed
water.
Histochemical staining for b-GAL activity
To understand the expression pattern of the R11 promoter trap re-
porter, b-GAL activity was assayed in adult tissues. Mice were killed
by CO2, and tissues were rapidly harvested, pinned on parafﬁn blocks,
and ﬁxed in freshly prepared 4% paraformaldehyde in phosphate-
buffered saline (pH 7.3) on ice for 1 hr. Fixed samples were washed
three times (30 min each) in Rinse Buffer [100 mM sodium phosphate
(pH 7.027.5), 2 mM MgCl2, 0.01% sodium deoxycholate, and 0.02%
Triton X-100]. Tissues were then stained for 12 to 14 hr in a humid-
iﬁed chamber at 37 in staining solution [Rinse Buffer plus 5 mM
potassium ferricyanide, 5 mM potassium ferrocyanide, and 1 mg/mL
X-GAL (Invitrogen, Carlsbad, CA) from a 25 mg/mL stock in dime-
thylformamide]. After staining, samples were rinsed in Rinse Buffer,
post-ﬁxed overnight in 10% formalin, and transferred to 70% ethanol.
Tissues were embedded in parafﬁn and sectioned serially at 5 mm.
Sections were counterstained with Nuclear Fast Red.
Cloning of the R11 insertion site using inverse PCR
Inverse polymerase chain reaction (PCR) was used to clone the
genomic insertion site of the R11 promoter trap vector. The inverse
PCR protocol was modiﬁed from that of Joslyn et al. (1991) as follows:
total genomic DNA was isolated from spleens of B6 R11/+ mice.
At o t a lo f1 6mg of DNA was digested at 37 nearly to completion,
ﬁrst with EcoRI and then with HindIII. The restriction enzymes
were then inactivated at 65 for 20 min. Digested DNA molecules
were ligated (T4 DNA ligase #10799009001, Roche, at a concentra-
tion of 5210 ng/mL) to maximize circularization (Ochman et al.
1990). Ligated DNAs were precipitated, washed, and resuspended
in 40 mL of TE-4 [10 mM Tris (pH 7.5), 0.1 mM EDTA]. Five
microliters of the ligated material was used for PCR experiments.
Long-range PCR was performed by the Roche Diagnostics protocol
(kit no. 11681834001) by using primers bGeo-D and SupF-A for
the HindIII digest. (All primer sequences are provided in Table 1.)
The PCR products were resolved on a 1% agarose gel and stained
with ethidium bromide. A ~1700-bp band was visualized on an
ultraviolet light box and excised. Agarose was removed from the
gel fragment using kit no. 28704 from QIAGEN (Valencia, CA).
The 1700-bp DNA fragment was then sequenced using a standard
Sanger protocol (Applied Biosystems, Carlsbad, CA) with separate
bGeo-D and SupF-A sequencing primers.
Genotyping the R11 and wild-type alleles in crosses
After the R11 insertion site was determined, primer pairs (R11-G2L/
R11-G4 and SupF-A/R11-G4) were synthesized to distinguish be-
tween the wild-type and the R11 alleles, respectively. Progeny mice
from crosses were genotyped from tail snip DNA using a three primer
system with Primers R11-G2L/R11-G4/and SupF-A (Table1). Stan-
dard PCR conditions were used with 2.0 mM MgCl2 and 0.8 mMo f
each primer (ﬁnal concentration). PCR was performed with 30 cycles
under the following cycling conditions: 94 (30 sec), 60 (30 sec), and
72 (1 min). The PCR product was run on a 2% agarose gel for size
fractionation. The product size of the R11 fragment is ~500 bp, and
the wild-type fragment is ~100 bp.
Cloning by 59 RACE-PCR of sequences downstream
of the R11 insertion
RACE-PCR was used to identify the promoter responsible for gene
expression driven by the R11 promoter trap insertion. Total RNA was
isolated from the spleens of R11/+ mice using TRIzol reagent (Invi-
trogen). A total of 80 mg of total RNA was used in the 59 RACE
protocol (Marathon cDNA Amplication Kit PT1115-1; Clontech,
Mountain View, CA). Here, ﬁrst-strand synthesis was performed us-
ing 1 mLo ft o t a lR N A( 7mg/mL) added to 1 mL of GSP-1 primer and
10 mL of reagent-grade dH2O. This mixture was heated to 80 for
5 min and rapidly chilled on ice. A total of 8 mL of Reverse Transcrip-
tion (RT) Mix [4 mL of 5X-RT Buffer (Invitrogen), 1 mLo f1 5m M
dNTP, 2 mLo f0 . 1m MD D T ,a n d1mL of Superscript II (Invitrogen)]
w e r ea d d e da n di n c u b a t e da t4 2  f o r9 0m i n ,1 5m i na t5 0 ,a n d1 5m i n
at 70.R N Aw a st h e nd i g e s t e db ya d d i n g1mL of RNase H and
incubating at 37 f o r2 0m i n .T ot a i lt h ec D N Aw i t hd T ,t h ee n t i r e
cDNA mixture was added to a Centricon-50 column (Millipore, Bill-
erica, MA), and the ﬁltrate was concentrated in vacuo to a volume of
10 mL. Then, 10 mL of Tailing Mixture [4 mLo f5 XT a i l i n gB u f f e r
(Invitrogen), 4 mLo f1m Md A T P ,1mLo fd H 2O, and 1 mLo f1 0 220 U
of TdT (Invitrogen)] were added to 10 mL of cDNA product and
incubated at 37 for 10 min. Terminal transferase was then inactivated
at 70 for 15 min.
59 RACE ﬁrst round ampliﬁcation: At o t a lo f1mL each of a series of
three test concentrations of dA tailed cDNA (direct, 1/25, 1/50) was
added to 49 mL of First Round PCR Mixture [5 mLo f1 0 XG i t s c h i e r ’s
Buffer (670 mM Tris, pH 8.8, 166 mM ammonium sulfate, 67 mM
MgCL2), 5 mLo fd N T P ,5mL of dimethyl sulfoxide, 1 mLo f2 mMQ T
primer, 1 mLo f2 5 mMQ 0 primer, and 1 mLo f2 5mM GSP-2 primer,
31 mLo fd H 2O]. The reaction was cycled as follows: 98 (5 min), hold
at 85 to add 1 mL of Taq (AmpliTaq; Perkin Elmer, Waltham, MA),
then 29 cycles of 48 (2 min), 72 (40 min), 93 (1 min), 56 (1 min),
and 72 (3 min), followed by 93 (1 min) and 72 (5 min) for product
extension.
59 RACE second round ampliﬁcation: At o t a lo f1mL of a 1/20
dilution of the ﬁrst round product was added to 49 mL of Second
Round PCR Mixture (5 mLo f1 0 XG i t s c h i e r ’s buffer, 5 mL of dNTP,
5 mL of dimethyl sulfoxide, 1 mLo f2 5mMQ 1 primer, 1 mLo f2 5mM
GSP-3 primer, 1 mL of 1.25 U AmpliTaq, and 32 mLo fd H 2O). The
570 | A. T. Thliveris et al.reaction was cycled 39 times as follows: 98 (3 min), 93 (1 min), 56
(1 min), and 72 (3 min). The product was brought to 93 for 1 min
followed by extension at 72 for 5 min. Then, 10 mL of this second
PCR product was resolved on a 1% agarose gel, revealing a single
~400-bp band. This band was excised, puriﬁed, cloned with the
TOPO-TA cloning kit (Invitrogen), and Sanger sequenced (using se-
quencing primer GSP-3) as described previously.
Western blotting of CBX5 protein
in R11/R11 homozygotes
Western blot analysis as described by Schlamp and Nickells (Schlamp
and Nickells 1996) was performed with the following modiﬁcations.
Protein was isolated from B6 R11/R11 spleens solubilized and soni-
cated in SBA [10% sodium dodecyl sulfate, 10 mM B-mercaptoethanol,
20% glycerol, 200 mM Tris (pH 6.8)]. Bradford analysis was used
to determine the protein concentration in each sample. Each lane was
loaded with 50 mg of soluble protein and the protein proﬁle resolved
on a 10% sodium dodecyl sulfate polyacrylamide gel, along with stan-
dard molecular weight markers. Gels were transblotted onto Immo-
bilon P membranes (Millipore), visualized using Ponceau S, and
blocked for 2 hr at room temperature in Tris-buffered saline (TBS)
containing 5% skim milk powder. Blots were then washed extensively
in TTBS (TBS plus 0.05% Tween 20) and incubated with primary
antibody [10 mL of 1/200 dilution of mouse monoclonal to CBX5
protein (Ayyanathan et al. 2003) in 2 mL of Blocking Buffer (TBS
and 5% skim milk)] overnight at 4 with continuous slow agitation.
The blot was washed as above and challenged for 3 hr at room
temperature with agitation using 1/2000 goat antirabbit secondary
antibody conjugated to alkaline phosphatase (Jackson Immuno-
Research Laboratories Inc., West Grove, PA.) Polypeptides were visual-
ized after color staining by 5-bromo-4-chloro-3-indolyl-phosphate and
nitro-blue tetrazolium.
RNA isolation and real-time PCR analysis
RNA was isolated from tissues frozen in liquid nitrogen using Trizol
reagent and cleaned up using RNeasy Columns (QIAGEN) per the
manufacturer’s protocol. RNA quantity and purity were assessed by
spectrophotometric analysis. Up to 10 mg of RNA was treated using
TURBO DNA-free (Ambion, Austin, TX) and inactivated per
the manufacturer’s protocol. cDNA was synthesized from 1 mg
of DNase-treated RNA using random hexamers and M-MLV reverse
transcriptase in the presence of SuperAseIn (Ambion). Quantitative
real-time PCR was conducted using an MJ Research Opticon 2 real-
time PCR cycler and SYBR Premix Ex Taq (Takara Bio Inc., Shiga,
Japan). The reactions contained 200 ng of cDNA and 200 nM ﬁnal
concentration of the primer pairs listed in Table 1. Several house-
keeping control genes were tested, including GAPDH, H2A.Z, TBP,
PGK-1, mSdha, Alas-1, and b-actin. b-actin was found to be consis-
tent between tumor and normal intestine and was used to normalize
all Cbx5 primer sets for each RT-PCR run. The b-actin primers used
are shown in Table 1. In addition, b-actin plasmid clones of each
of the Cbx5 primer sets were serially diluted and coordinately run
with each primer set to determine the absolute copy number for each
RT-PCR run. After correction for primer efﬁciency, the ﬁnal copy
numbers were determined from Ct values normalized to the b-actin
reactions for each sample.
RESULTS
Analysis of the R11 genomic insertion site and fusion
transcript identiﬁes the Cbx5 locus encoding the CBX5
(heterochromatin 1a) protein
Inverse PCR was used to identify the insertion site of the R11 trap
vector. DNA was isolated from the spleens of R11/+ mice and
digested with HindIII. A 1700-bp genomic fragment was isolated
n Table 1 Sequences of primers used for genomic PCR, RT-PCR, and real-time PCR analyses
Primer Sequence
b-actin-F 59 AACCCTAAGGCCAACCGTGAAAAG
b-actin-R 59 TGGCGTGAGGGAGAGCATAGC
bGeo-D (a) 59 TTGAGGACAAACTCTTCGCGGTC
SupF-A (b) 59 GGCAGATTTAGAGTCTGCTCC
R11-G2L (c) 59 CAGATCAGGCTTGACAGCAA
R11-G4 (d) 59 GAGCAGCAAGCTCTACCAAG
GSP-1 59 CCGTGCATCTGCCAGTTTGAGGGGA
GSP-2 59 CGACGACAGTATCGGCCTCA
GSP-3 59 CAGCTTTCCGGCACCGCTTC
QT 59 CCAGTGAGCAGAGTGACGAGGACTCGAGCTCAAGC(T)17
Q0 59 CCAGTGAGCAGAGTGACG
Q1 59 GAGGACTCGAGCTCAAGC
Ex1C-F (e) 59 CGTGCAGGCCTTAGCGTGAGTGAT
E2/3R 59 TATGGCCACCAGGTTCCGGAT
E2F4 59 GATCTGCCAGCCCGCCAA
E3R3 59 GGCTGTCCTCTTGGTCTTC
Hp1-BF (f) 59 CAGGGAAGGATCCGTTTTG
Hp-1-1R (g) 59 TGCACGGTTCCTCTGTGGTA
bGeoC-R (h) 59 CAGCTGGCGAAAGGGGGATGTG
Hp1-2F (i) 59 ATCTGCCAGCCCGCCAAG
Hp1-2R (j) 59 ATCGCCCCAGTTCGTTCTTT
Hp1-4R (k) 59 GCCTGTCCAACACCTTTTCC
Hp1-4F (l) 59 GCACACGACATGGGAAAGAA
Hp1-5R (m) 59 CAGCGCTGTTGGAGAAACTG
Insertion site of R11 59 TTTTGTTTTTATGTTAGTCTTATT
Each letter in parentheses corresponds to the location of that primer relative to the genomic map of the R11-Cbx5 locus in Figure 1. Bolded
nucleotides represent the genomic insertion site of the R11 promoter trap vector. PCR, polymerase chain reaction, RT, reverse transcription.
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promoter trap vector was identiﬁed (Table 1). This site was located
between the two upstream untranslated Cbx5 exons at position
103,049,787 bp (mouse genome assembly NCBI37/mm9; Figure 1A)
on chromosome 15 (Kent et al. 2002; Fujita et al. 2011). Mapping
crosses (summarized below) conﬁrmed the position of the R11 in-
sertion to the region containing the Cbx5 gene on chromosome 15.
Using spleen RNA from a R11/+ mouse, a 380-bp fusion transcript
was isolated by 59-RACE (Frohman et al. 1988). This fragment was
sequenced, and a 90-bp unique region was identiﬁed. A database
search (http://blast.ncbi.nlm.nih.gov/) localized this sequence to the
59 UTR of Cbx5. Real-time PCR of the wild-type allele connected this
59 unique sequence to the ﬁrst coding exon of Cbx5.
Two promoters control the transcription
of the Cbx5 locus
To investigate the impact of the R11 promoter trap insertion allele on
the CBX5 transcript proﬁle, exon connection experiments were de-
veloped, using RT PCR. Primers connecting the Cbx5 coding exons 4
to 5 conﬁrmed that RNA isolated from R11/R11 homozygous, R11/+
heterozygous, and +/+ wild-type mice each contained the full coding
sequence of Cbx5 in exons 4 and 5. Interestingly, the RT PCR splice
form connecting exon 1 (located 59 to the R11 insertion site) to exon 4
of the Cbx5 coding sequence was absent in spleen RNA from the R11
homozygote (Figure 1B). This result was conﬁrmed by quantitative
RT PCR assays using the same primers in exons 1 and 4 (Figure 1D).
The reduced level of the exon 124 splice form can be explained by the
strong transcription terminator present at the 39 end of the promoter-
trap sequence (Friedrich and Soriano 1991).
To investigate further the effect of the R11 promoter trap insertion
on CBX5 RNA expression, exon connection analyses were used to
analyze products from the Cbx5 coding region. Several distinct pop-
ulations of exon connection products were detected. Exon 1 tran-
scripts were spliced directly to exon 4 but were never associated
with exon 2 sequence (Figure 1B). Exon 2, located downstream of
the R11 insertion site, was connected to the downstream Cbx5 coding
sequence in exon 4 through splicing with exon 3 and rarely with an
alternative exon between 2 and 3 designated 2a (Figure 1B and data
not shown). Taken together, two populations of CBX5 transcripts
were conﬁrmed; one initiated at upstream promoter (P1) that contains
the exon 425c o d i n gr e g i o ne x c e p tw h e ni ti se f ﬁciently prematurely
terminated by the R11 insertion, and one initiated at a downstream
promoter (P2) that also contains the full coding region. These ﬁndings
are consistent with the validated RefSeq sequences of three distinct
full-length Cbx5 cDNAs from two distinct promoters (P1: RefSeq
NM_001076789; P2: RefSeqs NM_007626.3, NM_001110216.1). To-
gether, these observations support a two-promoter regulatory struc-
ture for the Cbx5 locus—upstream P1 and downstream P2.
Primers connecting exon 4 to exon 5 conﬁrmed that RNA isolated
from homozygous, heterozygous, and wild-type mice always carried
the full coding sequence of Cbx5, although at reduced levels in the
homozygote (Figure 1D). Analysis of CBX5 protein from the spleen
Figure 1 Structure and tran-
script proﬁle of the of Cbx5 re-
gion. (A) Intron2exon structure
of the Cbx5 locus located on
mouse chromosome 15. Primers
used (a2m) in genotyping, exon
connection, and real-time PCR
are listed in Table 1. 59 untrans-
lated exons (Ex123) and coding
exons (Ex427) are designated.
(B) Exon connection analysis us-
ing primers Hp1-BF and Hp1-4R
in exons 124 and primers Hp1-
2F and Hp1-BF in exons 224
using cDNA from spleens
of +/+, R11/+, and R11/R11
B6 animals. Products were re-
solved by agarose gel ele-
ctrophoresis and stained with
ethidium bromide. The splice
form exon 124 was absent
in the R11/R11 homozygote.
(C) Western blot analysis of total
protein extracts from spleens,
probed with a mouse monoclonal
CBX5 antibody, as described in
Materials and Methods.I n t a c t
CBX5 protein was present in both
the wild-type and R11/R11 ho-
mozygote. (D) Transcript levels
in spleen RNA determined by
real-time PCR, as described in
Materials and Methods.Am a r k e d
reduction in copy number of
coding transcript (Cbx5 exon 425) is noted in the R11/R11 homozygote. This ﬁnding is consistent with the notion that the upstream promoter
(P1) is responsible for the majority of the coding transcript of Cbx5.
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ure 1C). Thus, homozygosity for the R11 insertion does not com-
pletely eliminate expression of CBX5 protein in the spleen.
b-GAL staining of adult tissues in R11/+ heterozygous
adult mice
Widespread b-GAL staining in the R11 heterozygous fetal and neo-
natal mouse was ﬁrst described by Friedrich and Soriano (1991). In
the current study, E18 heterozygotes exhibited extensive, but not uni-
form, staining in all tissues examined (Figure 2).
In the adult, the patterns of b-GAL expression were much more
restricted, shown by the analysis of parafﬁn sections of various tissues
from adult mice (Figure 3). Strong positive staining was localized to
tissues presumed to be dividing, such as the lower proliferative zone in
the small intestine and the germinal centers in the spleen. We also
found b-GAL activity in nondividing tissues such as brain (Figure 3,
A2C), skeletal muscle (Figure 3E), and the lung (Figure 3F). These
patterns were found in both homozygous and heterozygous mice,
whereas wild-type mice were negative.
Effects of the R11 insertion on viability assayed
by transmission analysis
The family of Chromobox homolog proteins is involved not only in
heterochromatic gene silencing but also in a broad range of functions
encoded in euchromatin (reviewed by Kwon and Workman 2011).
We therefore investigated whether the R11 insertion element that
blunts P1-driven expression from the locus affected the production
of viable heterozygous and homozygous offspring. To enable a quan-
titative analysis of the effect of the R11 insertion on transmission to
viable B6 mice, genotyping primers were designed to distinguish
among homozygous, heterozygous, and wild type. The transmission
to viable progeny was investigated in two types of cross (Table 2).
First, heterozygous mice were intercrossed. At 7 to 10 days, homozy-
gous offspring were observed at a frequency of only 5%, rather than
the expected 25%. Second, a similar deﬁciency in viable homozygous
progeny was observed when heterozygous mice were backcrossed to
surviving homozygotes. Thus, homozygotes survive at reduced fre-
quencies, as scored at 7 to 10 days. Further, among the surviving adult
R11/R11 homozygotes, there were no overt phenotypic abnormalities.
These survivors do not appear to have acquired linked genetic sup-
pressors of lethality because they continue to transmit the R11
insertion to homozygous progeny at reduced frequency.
Induction of Cbx5 in intestinal adenomas
of ApcMin/+ mice
Strong b-GAL expression in the intestine of mice carrying the R11
insertion is limited to the lower proliferative zone of crypts. Mice
harboring the Min mutation of Apc in addition to the R11 insertion
give rise to b-GAL positive intestinal adenomas (Gould and Dove
1996, and Figure 4). Thus, the lacZ reporter element in the R11 in-
sertion serves as a developmental marker for the cells in the lower
proliferative zone of the intestine and in Min-induced tumors. The
level of CBX5 RNA expression within this developmental-neoplastic
lineage was investigated by quantitative transcript analysis of normal
and tumor tissue. CBX5 RNA transcripts harvested from equivalent
amounts of tumor and normal intestinal tissue of B6 ApcMin/+ mice
heterozygous and homozygous for the insertion were assayed by real
time PCR (Figure 5). As a control, several housekeeping genes were
assayed. b-actin was found to be the most consistently expressed
across all tissues and was used to normalize RNA levels (see Materials
and Methods). A two-way analysis of variance revealed a signiﬁcant
increase in average expression of CBX5 RNA in R11/+ heterozygous
tumor cells of 1.94 6 0.55 SE (log2 scale) compared with normal cells
(P ¼ 0.001). In R11/R11 homozygotes, the average expression of RNA
from the exon 425 coding region of Cbx5 was signiﬁcantly reduced
(22.72 6 0.64) as compared to wild type (P ¼ 0.0001). In tumors,
a nonsigniﬁcant reduction of CBX5 RNA level is observed in hetero-
zygotes compared with wild type (20.77 6 0.5; P ¼ 0.18). All Min-
induced tumors differ from all normal tissue samples, and the three
different genotypic classes differ from one another. However, within
the restricted statistical power created by small numbers of certain
classes in Figure 5, it cannot be concluded that these two sets of class
differences are correlated.
DISCUSSION
The structure of the R11 insertion has been established through the
following series of steps. First, RACE PCR has shown that expression
Figure 2 b-GAL expression in embryonic day 18 (E18) R11/+ hetero-
zygotes. (A) Whole R11/+ fetuses revealed ubiquitous staining of the
skin adjacent to limited staining of the denuded E18 fetus. (B) By
contrast, the denuded whole R11/+ fetus revealed b-GAL staining
limited to the ribcage and appendage tissue types. (C) No staining
was seen in the wild-type control E18 fetus. Ubiquitous staining was
observed in R11/+ spleen (D) and kidney (F). No staining was noted in
wildtype control spleen (E) and kidney (G). ap, appendage; rc, ribcage;
sk, skin. Scale bar = 500 mm (A and B), 1000 mm (C), or 50 mm( D 2G).
Volume 2 May 2012 | Cbx5 Regulation in Mice | 573from the b-Geo promoter trap lies under the control of the Cbx5 gene.
A cDNA fusion product was identiﬁed that joined b-Geo sequence to
an untranslated 59-proximal exon of Cbx5 (Figure 1). Next, inverse PCR
analysis localized the b-Geo promoter trap vector to a 59-proximal
intron of Cbx5 (Figure 1). Finally, exon connection experiments in-
volving the 59 exons of Cbx5 gave products that are consistent with
a model in which two distinct promoters (P1, upstream, and P2,
downstream) regulate the transcription of this gene (Figure 1A). This
model is consistent with the spliced expressed sequence tags identiﬁed
in the GenBank genome database and visualized through the
UC-Santa Cruz genome browser (http://genome.ucsc.edu/ and Kent
2002; Benson et al. 2004).
The sequence of the Cbx5 locus suggests a number of interactions
with transcription factors that reﬂect the in vivo expression pattern.
The mouse Cbx5 upstream promoter, P1, appears to be a bidirectional
promoter shared with hnRNPa1 that, by in silico analysis, has identiﬁ-
able binding sites for Myc and Tcf4 (Matys et al. 2006). Human Chip-
Seq ENCODE data from multiple laboratories show direct binding of
RNA polymerase 2, Myc, Tcf4,a n dc-Fos at P1 (Rosenbloom et al.
2010). This is consistent with our observation of expression from the
P1 promoter and expression of b-GAL activity in WNT-responsive
Min-induced tumors (Figure 4). In these tumors Tcf and b-catenin are
controlled by WNT signaling, leading to the expression of Myc
(reviewed by Myant and Sansom 2011). The downstream promoter,
P2, shows RNA polymerase 2 binding in human tumor and ES cell
lines, supporting the observation that CBX5 function is not completely
lost in the R11 homozygous mouse (Figure 1, B and D). We hypoth-
esize that, in the R11/R11 homozygote, independent initiation of tran-
scription at the P2 promoter drives exon 425 transcription during
development that is suboptimal for viability (Table 2).
It is interesting to speculate on the role of the Cbx5 protein
(heterochromatin 1a) in the biology of the crypt progenitor that is
ampliﬁed in Min-induced tumors. This protein has been reported to
interact with the origin recognition complex, ORF (Pak et al. 1997).
Figure 3 b-GAL expression in adult mouse
tissues of R11/+ heterozygotes. Adult tissues
from R11/+ mice were stained with X-GAL to
reveal b-GAL activity as described in Materi-
als and Methods. (A, C) Hippocampus (gr,
granular layer; ml, molecular layer; pz, prolif-
eration zone; CA1, pyramidal cells). (B) Cere-
bral cortex (ml, molecular layer; egl, external
granular layer). (D) Cardiac muscle (cm, car-
diac muscle cell). (E) Skeletal muscle (mb,
skeletal muscle bundle). (F) Lung (ac, alveolar
cells; as, alveolar sac; br, bronchioles; ce, co-
lumnar cells). (G) Spleen (cp, capsule; rp, red
pulp; tr, trabecula; wp, white pulp). (H) Kidney
(rt, renal tubule; gl, glomerulus). (I) Liver (hp,
hepatocytes; vn, vein). (J) Tongue (fp, ﬁliform
papilla; lp, lamina propria; mb, skeletal mus-
cle bundles). (K) Ovary (1, primary follicle; 2,
secondary follicle; gc, granulose cells; GF,
Graaﬁan follicle; oc, oocyte). (L) Skin (ct, con-
nective tissue; ep, epidermis; fc, fat cells; gl:
gland). All adult tissues stained positive for
b-GAL except cardiac muscle (D) and lung
(E). Scale bar ¼ 100 mm (A, B, F2L) or
50 mm( C 2E).
n Table 2 Transmission of the R11 allele from R11/+ X R11/+ intercrosses and R11/+ X R11/R11 backcrosses on the B6 background
Cross
R11/+ X R11/+ R11/+ X R11/R11
Genotype of Progeny No. Observed Expected No. Observed Expected
+/+ 64 (38%) 25% NA NA
R11/+ 95 (57%) 50% 95 (83%) 50%
R11/R11 8 (5%) 25% 20 (17%) 50%
Reported numbers represent live births tested at 7210 days of age. The distribution of observed genotypes among the progeny from each cross differed signiﬁcantly
from the expected ratios for Mendelian segregation (P , 0.001, x2 test). NA, not applicable.
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associated with transcriptionally active Drosophila chromatin
(Cryderman et al. 2005). Cbx5 has been shown to be up-regulated
in the breast cancer cell line MCF7 with corresponding increase in
protein levels (Thomsen et al. 2011). The requirement for controlled
replication of stem cells may involve an interaction between these
classes of positive action by Cbx5 protein and an antagonist such as
POF in Drosophila (Johansson et al. 2007).
Beyond the elements presumed to direct transcription, the Cbx5
locus contains other conserved elements not likely to involve canon-
ical promoters. Using the Multiz 30-way Alignment track in the
UCSC genome browser (Blanchette et al. 2004, mouse genome assem-
bly NCBI37/mm9, July 2007), ﬁve highly conserved noncoding
regions of unknown function are identiﬁed in the ﬁrst intron
(24,380 kbp in total length). These conserved regions range between
500 and 1000 bp in length and are shared among mammals; four of
the regions are found to be conserved further—through marsupials.
The ﬁfth region (between 103,057,150 and 103,057,450 on Chr. 15)
shows a high level of conservation among mammals and extends to
the chicken. No signiﬁcant open reading frames can be found span-
ning these conserved regions. Using exon connection, we have ob-
served no evidence for alternative splicing between exons 1 and 4 or
for alternatively initiated transcripts upstream of P2. In addition, there
is no evidence for a transcribed miRNA in the region on the basis of
published miRNA database and prediction analysis (Grifﬁths-Jones
2004, 2006; Weber 2005; Grifﬁths-Jones et al. 2008). Despite the lack
of evidence for transcription of these regions, their high level of con-
servation suggests that these are important noncoding regulatory ele-
ments. We shall return to discuss possible regulatory processes
involving these conserved sequences in intron 1.
Finally, the Cbx5 region of the mouse genome is highly susceptible
to transposon integration, deserving comment (Figure 6). The R11
insertion lies near the second exon of Cbx5, within the conserved
upstream promoter region. This region is an active area for trans-
poson integrations. From among approximately 51,000 localized
insertions that have been veriﬁed in the mouse genome, the Interna-
tional Gene Trap Consortium has identiﬁed and mapped 656 inde-
pendent insertions within the Cbx5 locus (To et al. 2004).This number
represents a frequency of more than 1 per 1000 of the total reported
insertions, nearly 20 times the frequency of insertions expected if the
insertions into genes were random. Plausibly, this preference reﬂects
the transcriptional activity of the Cbx5 locus during development:
active open chromatin is a preferred target for integration (Sandmeyer
et al. 1990). Of the ﬁve highly conserved regions within intron 1 of the
locus (Figure 6), insertions of transposons are found in or near the
four conserved noncoding regions but not in the most highly con-
served ﬁfth region. Perhaps even in ES cells loss of a regulatory role of
this element is lethal, or this element is refractory to integration
because of its structure at the time of integration.
The function of the Cbx5 locus has also been reﬂected by a
histochemical analysis of b-GAL activity in fetal and adult tissues
(Friedrich and Soriano 1991, and see Materials and Methods). In the
E18 fetus, the b-Geo gene is expressed ubiquitously in the skin. The
denuded E18 fetus reveals localized expression to appendages and rib
cage. By contrast, ubiquitous expression of the b-GAL marker gene is
found in the fetal spleen and kidney (Figure 2).
CBX5 function is particularly important for accurate mitotic
division, as judged by siRNA down-regulation of the alpha, but not
the beta and gamma isoforms in HeLa cells (De Koning et al. 2009).
Current studies of chromatin structure associate CBX5 protein with
late-replicating heterochromatin in mouse embryonic ﬁbroblasts
(Bachman et al. 2001). When somatic nuclei are reprogrammed with
extracts from Xenopus oocytes, the level of CBX5 (heterochromatin
1a) protein in these nuclei decreases (Bian et al. 2009). Thus, we
expect that the Cbx5 gene has an essential function for viability and
that this function is served by expression from both P1 and P2.
Although the expression of P1 serves primarily in fetal tissues and
dividing adult cells, it can also be observed in localized areas of even
Figure 4 b-GAL expression in normal and adenomatous tissue in the
small intestine. Tumor-bearing small intestine of a R11 homozygous
B6 ApcMin/+ mouse was stained with X-GAL to reveal b-GAL activity, as
described in Materials and Methods. Lower (A) and higher (B-C) mag-
niﬁcations reveal b-GAL staining of the lower proliferative zone in the
normal intestinal crypt (B) and the adenoma (C). Scale bar ¼ 50 mm.
Figure 5 Expression level (base 2 logarithm of copy number) of Cbx5.
Levels of the exon 425 coding region transcript in intestinal normal
and tumor samples are shown for animals from three genotypic classes
(+/+, R11/+, R11/R11). Two-way analysis of variance conﬁrms a signif-
icant increase in average expression in tumors of 1.94 6 0.55 (SE, log2
scale) compared with normal cells (P ¼ 0.001) as well as a signiﬁcant
reduction in average expression in R11/R11 homozygotes (22.72 6
0.64) as compared with wild type (P ¼ 0.0001). The observed reduc-
tion in R11 heterozygotes compared with wild type is not statistically
signiﬁcant (20.77 6 0.5, P ¼ 0.18).
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and lung interstitium (Figure 3).
Function in development and the
two-promoter hypothesis
The R11/R11 homozygote is not lethal but is found at frequencies
reduced from those expected for Mendelian transmission: in hetero-
zygous intercrosses, 5% of R11/R11 mice survive to weaning instead of
the predicted 25%. Among backcrosses of heterozygotes to homozy-
gotes, there were 17% R11/R11 mice instead of 50% (Table 2). The
surviving homozygotes seem to be normal and fertile, and their prog-
eny continue to display a low incidence of homozygous pups. Full-
length CXB5 protein is expressed in the spleens of these R11/R11
mice, as judged by Western analysis. However the predominant splice
form for the Cbx5 coding region, driven by the proposed upstream
promoter, is absent in the R11/R11 homozygote (Figure 1, B and D). In
the spleen, the level of exon 425 transcript from the coding region of
Cbx5 arises from a proposed promoter downstream of the R11 in-
sertion (Figure 1B) and is reduced by an order of magnitude in the
R11/R11 homozygote (Figure 1D; Figure 5).
Function in neoplasms
In Min-induced adenomas of the small intestine, exon 425 transcripts
of the Cbx5 coding region are elevated compared to normal intestine.
We interpret this elevation as a reﬂection of the ampliﬁcation of the
progenitor cell type in the tumor. As expected for this ampliﬁcation
model, this level of expression is observed in adenoma tissue for all
three genotypes: +/+, R11/+, and R11/R11. The evidence for further
deregulation of exon 425 transcript levels in R11/R11 tumors com-
pared to normal epithelium is not statistically signiﬁcant (Figure 5;
P ¼ 0.61).
The expression of transcripts containing exon 425i nMin-
induced adenomas deserves comment in light of the binding speciﬁc-
ities inferred from the ENCODE Chip-Seq data (Rosenbloom et al.
Figure 6 Physical map of mouse Chromosome 15 viewed centromere to telomere containing the Cbx5 locus as visualized using the UCSC mouse
genome browser (Kent et al. 2002; Fujita et al. 2011). The orientation of transcription is telomere to centromere with P1 oriented in the region
103,070,863 to 103,070,247, lying between Hnrnpa1 and the ﬁrst exon of Cbx5. P2 is oriented at 103,046,330 to 103,045,783. The tracks
included are: basepair position, chromosome band, RefSeq genes (Pruitt et al. 2005) in blue, placental mammal basewise conservation by PhyloP
(Siepel et al. 2005), Multiz alignments of human, rat, opossum, chicken, and stickleback (Blanchette et al. 2004), and the International Gene Trap
Consortium sequence tag alignments (Skarnes et al. 2004), where we added an asterisk to indicate the position of the R11 insertion. Peaks of
mammalian conservation are recognized by PhyloP with high peak heights in the coding region of Cbx5 and ﬁve peaks within intron 1. Two of
these ﬁve intronic peaks show conservation between mammals and chicken, as shown by the Multiz alignment track. Gene trap sequence tags are
color coded by the institution or source of the gene trap insertion and are available through the International Gene Trap Consortium (http://www.
genetrap.org/).
576 | A. T. Thliveris et al.2010). For the proposed upstream promoter, P1, both TCF and MYC
binding are inferred and have been shown to be active in breast cancer
cell lines (Thomsen et al. 2011). Because MYC is a direct downstream
target of WNT-dependent TCF function (via b-catenin), this pair of
binding activities formally constitutes a feedback loop. If MYC indu-
ces transcription from P1, the inferred feedback loop would have
positive parity and contribute to the developmental choice in the
normal crypt progenitor population and its ampliﬁed neoplastic de-
rivative. By contrast, if MYC represses transcription from P1, the
inferred feedback loop would have negative parity and would serve
a homeostatic function in regulating WNT-induced CBX5 function.
(The WNT-inhibitory function WIF1 may serve that same homeostatic
regulatory logic.)
The observation that exon 425 transcript levels are also expressed
in Min-induced tumors homozygous for the R11 insertion is paradoxi-
cal in light of the aforementioned ENCODE analysis (Rosenbloom
et al. 2010). How would these levels be driven if the distal P2 region
shows no TCF or MYC binding speciﬁcity? One possible resolution to
this issue would involve an additional transcription factor controlled
by b-catenin, driving transcription from P2. Another conceivable
resolution to this issue would involve long-range chromatin interac-
tion with P2, either by P1 or by a locus control region elsewhere in the
genome that is responsive to WNT and b-catenin.
The intricacies of gene expression uncovered by this initial analysis
of the R11 insertion in the Cbx5 locus of the mouse genome have been
developed by a molecular analysis of the spleen, the intestine, and
Min-induced intestinal tumors, coupled with a bioinformatic analysis
of the ENCODE database for the human genome. The observed ex-
pression of the locus in Min-induced adenomas is consistent with the
bioinformatic prediction of WNT-induced transcription from the
strong upstream promoter P1 and the known action of APC protein
to regulate WNT signaling. Novel insight has come from the bioin-
formatic identiﬁcation of a role for the WNT-dependent factor MYC
also acting at promoter P1. The inferred feedback loop needs to be
understood more fully in regard to its role in the homeostasis of
the self-renewing normal intestinal epithelium and any subtle loss
of control in the adenoma. Beyond these issues involving the strong
promoter P1, the secondary promoter P2 raises the further issues
of what drives its expression in normal tissues and in the adenoma
(Figure 5).
Vermeulen et al. (2010) have observed that only a minority of cells
in human colon cancers have activated WNT; these cells show stem
cell activity in xenograft assays. We have argued that this class of cell is
ampliﬁed in Min-induced adenomas. The promoters for the terminal
developmental genes for fatty acid binding protein and villin, cur-
rently used to drive Cre recombinase in generating conditional gene
knockouts, do not have this speciﬁcity for WNT and MYC. Thus, P1
(and perhaps P2) will be a useful new driver for experimentally ma-
nipulating the Min tumor lineage.
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